Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Sangamo Therapeutics, Inc. , a genomic medicine company, today announced that the American Society of Gene & Cell Therapy has accepted 20 Sangamo abstracts for presentation at the 27th ASGCT Annual...

Related Keywords

Kamy Pooler ,Greg Davis ,American Society Of Gene Cell Therapy ,Development Of Blood ,Head Of Research At Sangamo ,Development Of Modular Integrases Mints ,Nasdaq ,Head Of Technology At Sangamo ,Sangamo Therapeutics Inc ,Formulation Development ,Linkedin ,Exchange Commission ,Sangamo Therapeutics ,American Society ,Cell Therapy ,Modular Integrases ,Dravet Syndrome ,Meeting Presentations ,Central Nervous ,Normal Gene ,Protein Expression ,Human Disease Models ,Haploinsufficiency Using Zinc Finger Activators ,Zinc Finger Activator Platform ,Restore Normal Gene ,Cellular Models ,Repression Mediated ,Zinc Finger Repressors ,Therapeutic Approach ,Gene Activation Mediated ,Zinc Finger Activators ,Angelman Syndrome ,Tau Knockdown ,Potential Treatment ,Activation Mediated ,Zinc Finger Transcriptional Activators ,Phelan Mcdermid Syndrome ,Robust Zinc Finger Activation Platform ,Neurological Disorders ,Human Prion Expression ,Potential One Time Treatment ,Prion Disease ,That Exhibits Widespread Transduction ,Central Nervous System ,Cynomolgus Macaques ,Highly Potent Engineered ,Enables High Throughput ,Arrayed Epigenetic Regulator Screening Directly ,Cultured Neurons ,Drug Product Presentation ,Container Closure Selection ,Based Genomic Medicines ,Blood Brain Barrier Penetrant ,Receptor Targeted Capsid Engineering ,Manufacturing Process Related Stresses ,Novel Blood Brain Barrier Penetrant ,Finger Mediated Repression ,Cellular Disease Phenotype ,Patient Derived Cells ,Specific Zinc Finger Proteins ,Dosage Sensitive Transgenes ,Annual Report ,Markets ,